Cargando…
Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis
BACKGROUND: Recombinant factor VIIa (rFVIIa) has been used off-label as an adjunct in the reversal of warfarin therapy and management of hemorrhage after trauma. Only a handful of these reports are rigorous studies, from which results regarding safety and effectiveness have been mixed. There remains...
Autores principales: | Lombardo, Sarah, Millar, D, Jurkovich, Gregory J, Coimbra, Raul, Nirula, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887758/ https://www.ncbi.nlm.nih.gov/pubmed/29766126 http://dx.doi.org/10.1136/tsaco-2017-000134 |
Ejemplares similares
-
AAST statement on firearm injury
Publicado: (2018) -
Laboratory measures of coagulation among trauma patients on NOAs: results of the AAST-MIT
por: Kobayashi, Leslie M, et al.
Publicado: (2018) -
Anorectal emergencies: WSES-AAST guidelines
por: Tarasconi, Antonio, et al.
Publicado: (2021) -
Kidney and uro-trauma: WSES-AAST guidelines
por: Coccolini, Federico, et al.
Publicado: (2019) -
Postoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelines
por: Coccolini, Federico, et al.
Publicado: (2022)